BILIARY TRACT CANCER (BTC)
Clinical trials for BILIARY TRACT CANCER (BTC) explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCER (BTC) trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCER (BTC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes aim at Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called ST-01156 in people with advanced solid tumors (including Ewing sarcoma, liver cancer, and bile duct cancer) that have not responded to standard treatments. The drug works by breaking down a protein (RBM39) that cancer …
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE1 • Sponsor: SEED Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 10:02 UTC
-
New drug trial hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called TJ033721 (givastomig) in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 330 partici…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE1 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 26, 2026 09:51 UTC
-
New drug AVZO-1418 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called AVZO-1418 in people with advanced solid tumors that have spread. The main goals are to find a safe dose and see if the drug can shrink tumors. About 480 adults will take part in this first human trial.
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE1, PHASE2 • Sponsor: Avenzo Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:50 UTC
-
New hope for Hard-to-Treat cancers: experimental drug PT886 enters human trials
Disease control Recruiting nowThis study tests a new drug called PT886 in people with advanced stomach, pancreatic, or bile duct cancers that cannot be removed by surgery or have spread. The trial has two parts: first, finding the safest dose of PT886 alone, then testing it combined with chemotherapy or immun…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New combo therapy shows promise for tough bile duct cancer
Disease control Recruiting nowThis study tests a treatment that delivers chemotherapy directly to the liver (HAIC) combined with standard drugs for people with biliary tract cancer that cannot be removed by surgery. The goal is to shrink tumors enough so that surgery becomes possible, potentially improving su…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for bile duct cancer: experimental drug enters final testing phase
Disease control Recruiting nowThis study tests a new drug called nanvuranlat in 480 adults with advanced biliary tract cancer (bile duct cancer) that has already been treated. The goal is to see if nanvuranlat helps people live longer compared to standard treatments like chemotherapy or best supportive care. …
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE3 • Sponsor: J-Pharma Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Promising combo therapy targets Hard-to-Treat bile duct cancer
Disease control Recruiting nowThis study tests a new combination treatment for people with advanced bile duct cancer that has not responded to standard first-line therapy. The treatment uses a special form of the chemotherapy drug paclitaxel (polymer micellar) together with immunotherapy. The goal is to see i…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
New study aims to unlock secrets of Hard-to-Detect cancers
Knowledge-focused Recruiting nowThis study is collecting tissue and fluid samples from 160 people with suspected bile duct, liver, or pancreatic cancers. Researchers want to learn more about these cancers to develop better ways to diagnose and treat them. Participants will give extra samples during their regula…
Matched conditions: BILIARY TRACT CANCER (BTC)
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated May 26, 2026 10:02 UTC